test
a test article 8.31
Nice Insight
a-test-article-8.31
Nice Insight
Data-Driven Intelligence for the Life Sciences Industry
Pricing Reports | Custom Research | State of the Industry
Contact Us
Nice Insight helps life sciences organizations make smarter strategic, commercial, and operational decisions.
Since 2008, we have partnered with pharmaceutical companies, biotechs, CDMOs, CROs, investors, and suppliers to uncover market opportunities, evaluate competitive landscapes, benchmark capabilities, and understand the trends shaping the future of drug development and manufacturing.
500+
CDMOs and CROs Tracked Within the Nice Insight Database
1,900+
Manufacturing Sites Tracked Across NA, EU & APAC
18
Years Serving Life Sciences with Custom Research
CDMO Market Intelligence & Pricing Data
Nice Insight's Market Intelligence Reports provide access to proprietary data and insights unavailable through public sources.
Built from years of primary research, executive interviews, industry roundtables, and direct engagement with buyers and service providers, our reports examine what is happening across the outsourcing landscape and why.
Explore Nice Insight Reports
Pricing benchmarks across ten life sciences modalities
The commercial and operational factors influencing pricing decisions
Capacity trends, facility expansions, closures, and demand signals
500+ CDMOs and CROs tracked within the Nice Insight database
1,900+ manufacturing sites tracked across North America, Europe, and Asia-Pacific
Sponsor outsourcing behavior and purchasing trends
Custom Research, Surveys & Reports
Nice Insight's custom research services are designed to answer the questions that cannot be addressed through off-the-shelf reports alone.
Whether you are evaluating a new market opportunity, assessing brand awareness, understanding customer perceptions, or determining where a new technology fits, our team develops research programs tailored to your objectives.
Start Your Research Project
Technology and market fit assessments
Brand awareness and perception studies
Market sizing and opportunity analysis
Facility buildout feasibility
Voice-of-customer research
Investor and acquisition diligence support
State of the Industry
Each year, Nice Insight publishes its State of the Industry Report, a comprehensive assessment of the pharmaceutical outsourcing ecosystem and the forces shaping its future.
Developed by our team of scientists, analysts, and researchers, the report combines proprietary market data, executive roundtables, industry working sessions, and expert commentary to provide the context behind the headlines.
Read the 2026 State of the Industry
Funding and investment environments
Capacity constraints and utilization trends
Emerging technologies and evolving modalities
Changing sponsor expectations and outsourcing strategies
Competitive dynamics across the CDMO and CRO landscape
Market opportunities, risks, and future growth drivers
Knowledge Hub
Browse our collection of articles that give you insight into the CDMO market, broken down by therapeutic modality. You’ll learn the basics of manufacturing each type of therapy, how the manufacturing technology and CDMO market interact, how the regulatory and patent landscape influences the market, and much more.
mRNA / analytical
The mRNA Therapeutics Analytical Landscape
Nice Insight
NI-8-26-MA3
cell therapy
Core Analytical Frameworks in Cell Therapy Quality Control
Nice Insight
NI-8-26-MA38
Connect with
Nice Insight
Your Shortcut to Smarter Life Sciences Decisions
Let's discuss how Nice Insight's market research and pricing intelligence can deliver actionable insights for your business.